Homo sapiens Protein: MECP2
Summary
InnateDB Protein IDBP-383298.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol MECP2
Protein Name methyl CpG binding protein 2 (Rett syndrome)
Synonyms AUTSX3; MRX16; MRX79; MRXS13; MRXSL; PPMX; RS; RTS; RTT;
Species Homo sapiens
Ensembl Protein ENSP00000395535
InnateDB Gene IDBG-90808 (MECP2)
Protein Structure
UniProt Annotation
Function Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A. Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-containing DNA, with a preference for 5-methylcytosine (5mC) (By similarity). {ECO:0000250}.
Subcellular Localization Nucleus. Note=Colocalized with methyl-CpG in the genome.
Disease Associations Angelman syndrome (AS) [MIM:105830]: A neurodevelopmental disorder characterized by severe motor and intellectual retardation, ataxia, frequent jerky limb movements and flapping of the arms and hands, hypotonia, seizures, absence of speech, frequent smiling and episodes of paroxysmal laughter, open-mouthed expression revealing the tongue. {ECO:0000269PubMed:11283202}. Note=The disease may be caused by mutations affecting the gene represented in this entry.Mental retardation, X-linked, syndromic, 13 (MRXS13) [MIM:300055]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS13 patients manifest mental retardation associated with other variable features such as spasticity, episodes of manic depressive psychosis, increased tone and macroorchidism. {ECO:0000269PubMed:10986043, ECO:0000269PubMed:11007980, ECO:0000269PubMed:11309367, ECO:0000269PubMed:11805248, ECO:0000269PubMed:11885030, ECO:0000269PubMed:12161600, ECO:0000269PubMed:12325019, ECO:0000269PubMed:12615169, ECO:0000269PubMed:16966553}. Note=The disease is caused by mutations affecting the gene represented in this entry.Rett syndrome (RTT) [MIM:312750]: An X-linked dominant neurodevelopmental disorder, and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements, and develop microcephaly, seizures, autism, ataxia, mental retardation and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood. {ECO:0000269PubMed:10508514, ECO:0000269PubMed:10577905, ECO:0000269PubMed:10745042, ECO:0000269PubMed:10767337, ECO:0000269PubMed:10814719, ECO:0000269PubMed:10944854, ECO:0000269PubMed:10991688, ECO:0000269PubMed:10991689, ECO:0000269PubMed:11055898, ECO:0000269PubMed:11241840, ECO:0000269PubMed:11269512, ECO:0000269PubMed:11283202, ECO:0000269PubMed:11376998, ECO:0000269PubMed:11402105, ECO:0000269PubMed:11706982, ECO:0000269PubMed:11738883, ECO:0000269PubMed:12161600, ECO:0000269PubMed:12567420, ECO:0000269PubMed:12966522, ECO:0000269PubMed:12966523, ECO:0000269PubMed:15034579, ECO:0000269PubMed:15057977}. Note=The disease is caused by mutations affecting the gene represented in this entry.Autism, X-linked 3 (AUTSX3) [MIM:300496]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269PubMed:12770674}. Note=The disease may be caused by mutations affecting the gene represented in this entry.Encephalopathy, neonatal severe, due to MECP2 mutations (ENS-MECP2) [MIM:300673]: A neurodevelopmental disorder characterized by severe neonatal encephalopathy, developmental delay, mental retardation, microcephaly, seizures. Additional features include respiratory insufficiency and central hypoventilation, gastroesophageal reflux, axial hypotonia, hyperreflexia and dyskinetic movements. {ECO:0000269PubMed:11238684}. Note=The disease is caused by mutations affecting the gene represented in this entry. The MECP2 gene is mutated in Rett syndrome, a severe neurodevelopmental disorder that almost always occurs in females. Although it was first thought that MECP2 mutations causing Rett syndrome were lethal in males, later reports identified a severe neonatal encephalopathy in surviving male sibs of patients with Rett syndrome. Additional reports have confirmed a severe phenotype in males with Rett syndrome-associated MECP2 mutations.Mental retardation, X-linked, syndromic, Lubs type (MRXSL) [MIM:300260]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSL patients manifest mental retardation associated with variable features. They include swallowing dysfunction and gastroesophageal reflux with secondary recurrent respiratory infections, hypotonia, mild myopathy and characteristic facies such as downslanting palpebral fissures, hypertelorism and a short nose with a low nasal bridge. {ECO:0000269PubMed:16080119}. Note=The disease is caused by mutations affecting the gene represented in this entry. Increased dosage of MECP2 due to gene duplication appears to be responsible for the mental retardation phenotype.
Tissue Specificity Present in all adult somatic tissues tested.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 65 experimentally validated interaction(s) in this database.
They are also associated with 10 interaction(s) predicted by orthology.
Experimentally validated
Total 70 [view]
Protein-Protein 58 [view]
Protein-DNA 10 [view]
Protein-RNA 0
DNA-DNA 2 [view]
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 10 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0003682 chromatin binding
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0003714 transcription corepressor activity
GO:0003729 mRNA binding
GO:0005515 protein binding
GO:0008134 transcription factor binding
GO:0008327 methyl-CpG binding
GO:0010385 double-stranded methylated DNA binding
GO:0019904 protein domain specific binding
GO:0035197 siRNA binding
GO:0044822 poly(A) RNA binding
GO:0047485 protein N-terminus binding
Biological Process
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0001662 behavioral fear response
GO:0001666 response to hypoxia
GO:0001964 startle response
GO:0001976 neurological system process involved in regulation of systemic arterial blood pressure
GO:0002087 regulation of respiratory gaseous exchange by neurological system process
GO:0006020 inositol metabolic process
GO:0006122 mitochondrial electron transport, ubiquinol to cytochrome c
GO:0006342 chromatin silencing
GO:0006349 regulation of gene expression by genetic imprinting
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006541 glutamine metabolic process
GO:0006576 cellular biogenic amine metabolic process
GO:0007268 synaptic transmission
GO:0007416 synapse assembly
GO:0007420 brain development
GO:0007585 respiratory gaseous exchange
GO:0007612 learning
GO:0007613 memory
GO:0007616 long-term memory
GO:0008104 protein localization
GO:0008211 glucocorticoid metabolic process
GO:0008284 positive regulation of cell proliferation
GO:0008344 adult locomotory behavior
GO:0008542 visual learning
GO:0009405 pathogenesis
GO:0009791 post-embryonic development
GO:0010468 regulation of gene expression
GO:0016358 dendrite development
GO:0016571 histone methylation
GO:0016573 histone acetylation
GO:0019230 proprioception
GO:0019233 sensory perception of pain
GO:0021549 cerebellum development
GO:0021591 ventricular system development
GO:0030182 neuron differentiation
GO:0031061 negative regulation of histone methylation
GO:0031175 neuron projection development
GO:0032048 cardiolipin metabolic process
GO:0033555 multicellular organismal response to stress
GO:0035067 negative regulation of histone acetylation
GO:0035176 social behavior
GO:0040029 regulation of gene expression, epigenetic
GO:0042551 neuron maturation
GO:0043524 negative regulation of neuron apoptotic process
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045893 positive regulation of transcription, DNA-templated
GO:0046470 phosphatidylcholine metabolic process
GO:0048167 regulation of synaptic plasticity
GO:0050432 catecholamine secretion
GO:0050884 neuromuscular process controlling posture
GO:0050905 neuromuscular process
GO:0051965 positive regulation of synapse assembly
GO:0060079 regulation of excitatory postsynaptic membrane potential
GO:0060291 long-term synaptic potentiation
Cellular Component
GO:0000792 heterochromatin
GO:0005615 extracellular space
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005829 cytosol
Protein Structure and Domains
PDB ID
InterPro IPR001739 Methyl-CpG DNA binding
IPR014756 Immunoglobulin E-set
IPR016177 DNA-binding domain
IPR017353 Methyl-CpG binding protein MeCP2
PFAM PF01429
PRINTS
PIRSF PIRSF038006
SMART SM00391
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P51608
PhosphoSite PhosphoSite-P51608
TrEMBL
UniProt Splice Variant
Entrez Gene 4204
UniGene Hs.714077
RefSeq NP_001104262
HUGO HGNC:6990
OMIM 300005
CCDS CCDS48193
HPRD 02050
IMGT
EMBL AF030876 AF158180 AJ132917 AY541280 BC011612 BX538060 L37298 X89430 X94628 X99686 Y12643
GenPept AAC08757 AAC32737 AAF33023 AAH11612 AAS55455 CAA61599 CAA64331 CAA68001 CAA73190 CAB46446 CAD97991